drugset / Trial / NCT03609294
A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety/tolerability when administrated fixed dose combination of Fimasartan/Linagliptin and when co-administrated Fimasartan and Linagliptin.
Timeline
- Start
- 2018-07-18
- Primary completion
- 2019-03-04
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fimasartan | Small molecule | 120 mg | — |
| Subject | Linagliptin | Small molecule | 5 mg | — |